Christopher Hwang
Chief Tech/Sci/R&D Officer at TRANSCENTA HOLDING LIMITED
Profile
Christopher Hwang is currently the Chief Technology Officer & Executive VP at Transcenta Holding Ltd.
Prior to this, he worked at Genzyme Corp.
and Sanofi as a Senior Director from 1992 to 2016.
He received his undergraduate degree from Massachusetts Institute of Technology in 1985 and his doctorate degree from the same institution in 1992.
Christopher Hwang active positions
| Companies | Position | Start |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Chief Tech/Sci/R&D Officer | 2019-01-31 |
Former positions of Christopher Hwang
| Companies | Position | End |
|---|---|---|
| SANOFI | Director/Board Member | 2016-08-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 2016-01-31 |
Training of Christopher Hwang
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SANOFI | Commercial Services |
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher Hwang
